Work

Хлодитан, мітотан, о,п’-ДДД — сучасні погляди й оцінки

Year: 2017
Type: article
Abstract: Clinical and experimental data of studies on o,p’-DDD (mitotane, lisodren) are summarized in the review. Clinical experience indicates the effectiveness of the o,p’-DDD use in patients with inoperable cancer of the adrenal cortex. It is also used to treat the Itsenko – Cushing’s disease and hypercorticism caused by ectopic ACTH secretion.o,p’-DDD causes a number of structural and biochemical changes that cause the suppression of the steroid hormone synthesis and the development of apoptosis in cells of the adrenal cortex. The decrease in the activity of NADP-reducing enzymes, the decrease in glutathione content, and the change in the composition and properties of mitochondrialmembranes are of particular importance among the biochemical disorders caused by o,p’-DDD in the adrenal cortex. Probably an impairment of the biochemical properties of mitochondria lies at the basis of the adrenocorticolytic action of o,p’-DDD.
Language: Ukrainian
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2944325776
FWCI:
Cites: 55
Cited by: 1
Related to: 10